首页> 外文期刊>Nature reviews. Urology >Therapy: Intralesional nicardipine: another calcium channel blocker shown to be effective in patients with Peyronie's disease.
【24h】

Therapy: Intralesional nicardipine: another calcium channel blocker shown to be effective in patients with Peyronie's disease.

机译:治疗:腹膜内尼卡地平:另一种钙通道阻滞剂对佩罗尼氏病患者有效。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The search for an effective nonsurgical treatment for patients with Peyronie's disease (PD), a condition characterized by the development of fibromatosis in the tunica albuginea resulting in pain and abnormal penile curvature, has yet to yield an approach with satisfactory efficacy. Among the many treatments to be tested in these patients, such as shock wave therapy, radiation therapy, an array of oral agents, and intralesional injection of steroids or interferons-all of which have shown poor efficacy-intralesional administration of the non-dihydropyridine calcium channel blocker verapamil has had reasonably promising results.
机译:寻找一种有效的非手术疗法来治疗佩罗尼氏病(PD),这种疾病的特征在于白膜纤维化病的发展,导致疼痛和阴茎弯曲异常,但这种方法尚未产生令人满意的疗效。在这些患者中要测试的许多治疗方法中,例如冲击波治疗,放射治疗,一系列口服药物以及病灶内注射类固醇或干扰素,所有这些方法均显示出较差的效果,非二氢吡啶类钙的内注射通道阻滞剂维拉帕米有相当可观的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号